However, immunohistochemistry studies have been somewhat controversial and no subtype-specific data have been reported despite the observation of RNA-based studies that in oestrogen receptor-positive (ER+) breast cancer, high GR gene expression correlated with good outcome [9,10,11,12,13,14,15]. This evidence concerns the gene NR3C1 and breast carcinoma.